Background: Gonorrhea is the second most commonly reported sexually transmitted infection in Canada. Between 1991 and 1997, Canada experienced a sharp decline in the rates of reported cases of gonorrhea, followed by a steady incline.
Introduction
Gonorrhea has been nationally notifiable since 1924 and is the second most commonly reported sexuallytransmitted infection (STI) in Canada. Gonorrhea is a genital bacterial infection caused by Neisseria gonorrhoeae and if left untreated, can lead to complications for both sexes. There can be severe consequences for females, including pelvic inflammatory disease, which often leads to chronic abdominal pain, infertility and ectopic pregnancy. In males, untreated infections can result in epididymitis and rare cases of infertility. An uncommon complication of gonorrhea is the spread of infection to the blood stream and joints (1) . Like other STIs, gonorrhea increases the risk of HIV acquisition and transmission, possibly by increasing the concentration of HIV target cells in genital secretions and viral shedding (2).
Between 1991 and 1997, Canada experienced a sharp decline in the rates of reported cases of gonorrhea and rates were similar between males and females. After 1997, rates began to rise (3). 
Methods

Data collection
Data on laboratory-confirmed gonorrhea cases were reported to the Canadian Notifiable Disease Surveillance System (CNDSS) by provincial and territorial health authorities according to the Agency's Case Definitions for Communicable Diseases under National Surveillance (5) (see box below). Data are submitted in a variety of formats (e.g., line-listed electronic, paper-based case reports, or aggregate data) and are verified and loaded into the CNDSS database by Agency personnel.
Case definitions of confirmed case of gonorrhea
Laboratory-evidence of infection in genitourinary or extra-genital specimens: 
Data analysis
Gonorrhea data extracted from the CNDSS were analyzed by Centre for Communicable Diseases and Infection Control (CCDIC) staff. Rates were calculated by age group and sex using population estimates obtained from the Statistics Canada Demography Division. Rate change calculations were made on unrounded figures for greater precision. Surveillance is considered to be within the mandate of Federal/Provincial/Territorial (F/P/T) programs and does not constitute human research; therefore, no research ethics board approval was sought.
Results
In 2012, 12,561 cases of gonorrhea were reported through the CNDSS, corresponding to a rate of 36.2 per 100,000. The 2012 rate was a 38.9% increase from the rate of 26.0 per 100,000 in 2003. Over this ten-year time frame, rates increased among both males and females; males experienced a 29.1% relative rate increase while females experienced a 53.9% relative rate increase. Around 2006, rates of reported cases of gonorrhea began to show signs of stabilizing, with minor fluctuations from year to year. (Figure 1 ).
Figure 1: Overall and sex-specific rates of gonorrhea, 2003 to 2012, Canada
Rates of reported cases of gonorrhea in 2012 were higher among females than males in those less than 25 years of age; but were higher in males than females among those aged 25 years and over (Figure 2 ). The highest rates of gonorrhea were observed among males and females aged 20 to 24.
Between 2003 and 2012, rates of reported cases of gonorrhea increased among both males and females aged 10 and above. The greatest relative rate increase observed among males was in those aged 10 to 14 years (262.0%), from 0.5 to 1.7 per 100,000. Over this ten-year time frame, the highest relative increase observed among females was in those aged 60 and over (188.0%, from 0.2 to 0.7 per 100,000), though females in this age group exhibited the lowest rate of gonorrhea as compared to females in other age groups (data not shown). 
Discussion
Recent trends in the rates of reported cases of gonorrhea in Canada have shown overall increases, despite some year-to-year variation. The increases in rates since the late 1990s may be at least partly explained more sensitive testing methods and improved case finding (6).
Antimicrobial resistance may also play a significant role in the increase in reported rates of gonorrhea, as the proportion of isolates resistant to a number of antibiotics has increased over time, (7) which may lead to treatment failure and a longer duration of infectiousness in affected patients. Emerging antimicrobial resistance in gonorrhea has led to changes in treatment recommendations across Canada and elsewhere (8, 9, 10, 11) .
In 2012, the overall rates of reported cases of gonorrhea were substantially lower in Canada at 36.2 per 100,000 compared to the United States (107.5 per 100,000) (12), Australia (58.9 per 100,000) (13) and England (48.1 per 100,000) (14) . There was considerable variability in the differences observed across sexes; in Australia and England, gonorrhea rates were more than twice as high among males as compared to females, while the differences between sexes in Canada and the United States were less pronounced.
In conclusion, over a 10-year period, gonorrhea rates have increased almost 40% and these increases are particularly pronounced among young adults. While the reasons for these increases are likely multifactorial, it is possible that increasing gonococcal resistance to many available treatments has contributed to observed trends and should continue to be monitored. 
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